ClassID:

97080

C07K14/81 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof Protease inhibitors

Sub-classes:
Recent Application in this class:
#1
20260130975
2026-05-14

INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF

#2
20250250325
2025-08-07

Methods of Manufacturing Alpha-1 Antitrypsin Compositions For Treatment of Disease Disorders

#3
20250230209
2025-07-17

Isolation of Autologous Acellular Biological Therapeutics

#4
20250205319
2025-06-26

SYSTEMS, COMPOSITIONS, AND METHODS FOR TRANSPLANTATION

#5
20250145945
2025-05-08

CULTURE MEDIA FOR CULTURING PLURIPOTENT STEM CELLS IN SUSPENSION

#6
20250066415
2025-02-27

SYSTEMS FOR EXTRACTING PROTEINS FROM A BLOOD-BASED MATERIAL

#7
20250042947
2025-02-06

PEPTIDE LIBRARY AND USE THEREOF

#8
20240400649
2024-12-05

MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE

#9
20240398884
2024-12-05

PLANT MESSENGER PACKS ENCAPSULATING POLYPEPTIDES AND USES THEREOF

#10
20240360200
2024-10-31

KLK5 INHIBITORY PEPTIDE

#11
20240218049
2024-07-04

COMPOSITIONS AND METHODS FOR TREATMENT OF NETHERTON SYNDROME WITH LEKTI EXPRESSING RECOMBINANT MICROBES

#12
20240002472
2024-01-04

ULINASTATIN POLYPEPTIDES

#13
20230272445
2023-08-31

GLYCOSYLATION OF PROTEINS

#14
20230234995
2023-07-27

CHO CELL-DERIVED PROTEIN SECRETORY FACTORS AND EXPRESSION VECTORS COMPRISING THE SAME

#15
20230227523
2023-07-20

Fusion proteins comprising an engineered knottin peptide and uses thereof

#16
20230059111
2023-02-23

Translatable molecules and synthesis thereof

#17
20230050888
2023-02-16

HAPLOID INDUCTION COMPONDS AND METHODS FOR USE THEREOF

#18
20220402969
2022-12-22

Methods for Extracting Proteins from a Blood-Based Material

#19
20220380801
2022-12-01

TRIPARTITE SYSTEMS FOR PROTEIN DIMERIZATION AND METHODS OF USE

#20
20220306725
2022-09-29

KLK5 inhibitory peptide

#21
20220228172
2022-07-21

Novel Mechanism to Control RNA Virus Replication and Gene Expression

#22
20220155309
2022-05-19

FUSION PROTEIN OF ANTIGEN-BINDING PROTEIN AND FLUORESCENT PROTEIN OR FLUORESCENCE-LABELED TAG PROTEIN

#23
20220106384
2022-04-07

Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8

#24
20220099684
2022-03-31

Inter-alpha inhibitor proteins

#25
20220017638
2022-01-20

METHOD OF TREATING ATHEROSCLEROSIS

#26
20210393750
2021-12-23

INTER-ALPHA INHIBITOR PROTEINS AND METHODS OF USE THEREOF

#27
20210348159
2021-11-11

COMPOSITIONS AND METHODS FOR DELIVERING TRANSGENES

#28
20210340221
2021-11-04

KLK5 inhibitory peptide

#29
20210277090
2021-09-09

Ulinastatin polypeptides

#30
20210262000
2021-08-26

Glycosylation of proteins

#31
20210261608
2021-08-26

Methods for extracting proteins from a blood-based material

#32
20210206824
2021-07-08

Fusion proteins comprising an engineered knottin peptide and uses thereof

#33
20210130413
2021-05-06

MODIFIED AAV CAPSIDS AND USES THEREOF

#34
20210061886
2021-03-04

Modified anti-inflammatory proteins and method of use

#35
20210060116
2021-03-04

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

#36
20210032313
2021-02-04

KLK5 INHIBITORY PEPTIDE

#37
20210003552
2021-01-07

Methods for extracting A1P1 and albumin from blood plasma

#38
20210000973
2021-01-07

Recombinant adeno-associated viruses encoding serpin peptides and uses thereof

#39
20200362018
2020-11-19

INHIBITORS OF THE 20S PROTEASOME

#40
20200354407
2020-11-12

Peptide inhibitors of insulin-degrading enzyme

#41
20200308219
2020-10-01

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

#42
20200291096
2020-09-17

BICYCLIC PEPTIDE LIGAND STING CONJUGATES AND USES THEREOF

#43
20200222551
2020-07-16

COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES

#44
20200207837
2020-07-02

Peptides inhibiting KLK1, KLK4, or KLK4 and KLK8

#45
20200199179
2020-06-25

Peptide library and use thereof

#46
20200057065
2020-02-20

Detection, identification, and purification of degradative and non-degradative enzymes in biological samples

#47
20190309089
2019-10-10

Method of treating atherosclerosis

#48
20190284544
2019-09-19

Methods and composition for detecting CAPN5

#49
20190284526
2019-09-19

Culture media for culturing pluripotent stem cells in suspension

#50
20190274290
2019-09-12

GENETICALLY MODIFIED MOUSE MODEL FOR HUMAN HEPATOCYTE XENOTRANSPLANTATION

#51
20190248873
2019-08-15

Programmable protein circuits in living cells

#52
20190169231
2019-06-06

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

#53
20190083589
2019-03-21

METHODS FOR PRODUCING PEPTIDES AND USES THEREOF

#54
20190055282
2019-02-21

Methods for extracting proteins from a blood-based material

#55
20190046617
2019-02-14

Systems, compositions, and methods for transplantation

#56
20190040116
2019-02-07

Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes

#57
20190040100
2019-02-07

Peptide having activity to improve skin condition and use thereof

#58
20180327471
2018-11-15

Translatable molecules and synthesis thereof

#59
20180318257
2018-11-08

PDE4 modulators for treating and preventing immune reconstitution inflammatory syndrome (IRIS)

#60
20180306772
2018-10-25

Methods for extracting proteins from blood plasma

#61
20180305675
2018-10-25

Intein-modified proteases, their production and industrial applications

#62
20180282368
2018-10-04

Method for separating and purifying α2-macroglobulin from Cohn Fraction IV precipitation

#63
20180250416
2018-09-06

COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES

#64
20180136234
2018-05-17

Method for clinically and pathologically monitoring Alzheimer's disease through concentration of amyloidbeta in plasma

#65
20180037613
2018-02-08

Peptides and uses thereof

#66
20170282095
2017-10-05

Process For Isolation of Plasma or Serum Proteins

#67
20170274013
2017-09-28

WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS

#68
20170030928
2017-02-02

Protein biomarkers for immune assessment and prediction of transplant rejection

#69
20170029470
2017-02-02

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#70
20160376634
2016-12-29

High-selectivity contact activation inhibitor based on infestin-4

#71
20160376305
2016-12-29

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

#72
20160347822
2016-12-01

Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema

#73
20160229905
2016-08-11

Modified anti-inflammatory proteins and method of use

#74
20160229896
2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#75
20160153983
2016-06-02

BIOMARKERS, METHODS AND KITS FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS

#76
20160102311
2016-04-14

Protection against ionizing radiation and chemotherapy toxicity via latexin regulation

#77
20160009757
2016-01-14

Process for isolation of plasma or serum proteins

#78
20150361127
2015-12-17

METHODS FOR ISOLATING BLOOD PRODUCTS FROM AN INTER-ALPHA INHIBITOR PROTEIN-DEPLETED BLOOD PRODUCT MATERIAL

#79
20150267206
2015-09-24

Multiprotein expression cassettes

#80
20150246099
2015-09-03

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases

#81
20150197546
2015-07-16

Peptide library and use thereof

#82
20150166624
2015-06-18

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

#83
20150158931
2015-06-11

CYSTEINE PROTEASE CAPTURING AGENTS

#84
20150089683
2015-03-26

Transgenic plants with enhanced traits

#85
20150073125
2015-03-12

Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS)

#86
20150044162
2015-02-12

ANTICANCER FUSION PROTEIN

#87
20140371152
2014-12-18

Amyloid β-protein-specific production-inhibiting polypeptide

#88
20140357543
2014-12-04

Proteinaceous protease inhibitor and protein solution and detergent composition containing it

#89
20140348859
2014-11-27

Compositions, methods and uses for alpha-1 antitrypsin fusion molecules

#90
20140228540
2014-08-14

POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS

#91
20140154285
2014-06-05

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

#92
20140073518
2014-03-13

Fusion proteins comprising an engineered knottin peptide and uses thereof

#93
20140050727
2014-02-20

ANTI-CD14 ANTIBODY FUSION PROTEIN

#94
20140045742
2014-02-13

Serpin-finger fusion polypeptide

#95
20130310305
2013-11-21

Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis

#96
20130095108
2013-04-18

Factor XII inhibitors for treating interstitial lung disease

#97
20130065829
2013-03-14

PEPTIDES AND SUPPORTED PEPTIDES FOR TREATING SKIN DISEASES

#98
20130012453
2013-01-10

Acceleration Of Wound Healing By A Tissue Inhibitor Of Metalloproteinases (TIMP) Linked To Glycosylphosphatidylinositol (GPI)-Anchors

#99
20130005947
2013-01-03

Method for removing a lytic enzyme from a heterogeneous mixture

#100
20120277412
2012-11-01

Polynucleotide encoding anti-CD14 antibody fusion protein

#101
20120263745
2012-10-18

Antichlamydial agents

#102
20120231013
2012-09-13

POLYPEPTIDES THAT BIND TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS

#103
20120195859
2012-08-02

RECOMBINANT PROBIOTIC BACTERIA FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY BOWEL DISEASE (IBD) AND IRRITABLE BOWEL SYNDROME (IBS)

#104
20120083423
2012-04-05

Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis

#105
20120028965
2012-02-02

Compounds useful as protein kinase inhibitors

#106
20110230405
2011-09-22

Peptides and Supported Peptides for Treating Skin Diseases

#107
20110200541
2011-08-18

RECOMBINANT PREPARATION OF BROMELAIN INHIBITORS AND BROMELAIN INHIBITOR PRECURSOR

#108
20110183888
2011-07-28

Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases

#109
20100331261
2010-12-30

Use of alpha-1-antitrypsin for the preparation of drugs for the treatment of chronic fatigue syndrome

#110
20100216701
2010-08-26

Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes

#111
20100087628
2010-04-08

ISOLATION AND SEPARATION OF MINIMALLY DENATURED POTATO PROTEINS AND PEPTIDES

#112
20100087382
2010-04-08

Inhibitors of Hepatitis C NS3 Protease

#113
20100016242
2010-01-21

MYOSIN LIGHT CHAIN KINASE INHIBITORS AND METHODS OF USE

#114
20090281082
2009-11-12

Compounds useful as protein kinase inhibitors

#115
20090241207
2009-09-24

Expression of heterologous genes according to a targeted expression profile

#116
20090180995
2009-07-16

NOVEL ANTICOAGULANT POLYPEPTIDES AND COMPLEX

#117
20090176965
2009-07-09

Sericin Having Improved Antioxidant and Tyrosinase Inhibitive Abilities by Irradiation, and Methods of Making and Using the Same

#118
20090155270
2009-06-18

CASPASE INHIBITORS, ESPECIALLY CASPASE 3 INHIBITORS, FOR THE TREATMENT OF INFLUENZA

#119
20090111160
2009-04-30

Compositions comprising bowman-birk protease inhibitors and variants thereof

#120
20080311051
2008-12-18

Caspase-2 inhibitors and their biological applications

#121
20080286290
2008-11-20

Anti-CD14 antibody fusion protein

#122
20080269139
2008-10-30

FGF-5 Supported and Binding Peptides

#123
20080181892
2008-07-31

Binding Domain Fusion Protein

#124
20080113917
2008-05-15

Tgfbeta Supported and Binding Peptides

#125
20080026459
2008-01-31

Isolation, selection and propagation of animal transgenic stem cells

#126
20070299251
2007-12-27

Process for isolation of plasma or serum proteins

#127
20070172489
2007-07-26

Caspase inhibitors, especially caspase 3 inhibitors, for the treatment of influenza

#128
20070140972
2007-06-21

Targeting compositions and preparation therof

#129
20060222638
2006-10-05

Cholesterol biosynthesis pathway modulators and uses thereof

#130
20060216807
2006-09-28

Membrane for removing proteases from liquids

#131
20060045878
2006-03-02

Pancreas-derived plasminogen activator inhibitor

#132
20050261196
2005-11-24

Myosin light chain kinase inhibitors and methods of use

#133
20050260708
2005-11-24

Proteases and protease inhibitors

#134
20050245431
2005-11-03

Membrane, device and method for removing proteases from liquids

#135
20050238607
2005-10-27

FGF-5 supported and binding peptides

#136
20050227343
2005-10-13

Novel human protease inhibitor proteins and polynucleotides encoding the same

#137
20050209143
2005-09-22

Protein from horn fly saliva that disrupts hemostasis

#138
20050203026
2005-09-15

Peptides and supported peptides for treating skin diseases

#139
20050202535
2005-09-15

Bacterial expression of bowman-birk protease inhibitors and variants thereof

#140
20050201999
2005-09-15

Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases

#141
20050196858
2005-09-08

Isolation, selection and propagation of animal transgenic stem cells

#142
20050123511
2005-06-09

Dna vaccine

#143
20050059816
2005-03-17

Novel human protease inhibitor proteins and polynucleotides encoding the same

#144
20050037474
2005-02-17

Method for controlling the yield and purity of proteinase inhibitor II during extraction

#145
20050010973
2005-01-13

Expression cassettes for producing plants with increased levels of essential amino acids

#146
16818631
2022-11-01

Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

#147
15835137
2021-11-23

Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

#148
15679896
2020-11-10

Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment

#149
15600267
2020-03-17

Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

#150
14954387
2017-05-23

Protease inhibitor: protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria

#151
14624460
2017-08-22

Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment

#152
14135003
2015-12-01

Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria